The convalescent plasma roller coaster
The FDA's about-face on emergency approval of convalescent plasma raises questions about the level of evidence we need for Covid-19 treatments, and the role of politics in these decisions. More
Covid-19 puts more pressure on state budgets
State budgets have been squeezed over the past decade due in large part to the rising cost of health care, and Covid-19 is only making it worse. What can we do about this problem? More
Remdesivir report sparks more debate on drug price value
How much should remdesivir cost? This question puts two drug-value organizations at odds. More
Video: Science’s Viral Misinformation
Watch the video of Shannon Brownlee and Jeanne Lenzer discussing pandemic misinformation in a Future Tense conversation. More
Paying attention to the mental health effects of lockdown
Even though we have saved lives by locking down, we still have to address the effects of this decision on our country's mental health. More
Pharma sales reps still visiting doctors in the pandemic
Visits from pharmaceutical sales reps haven't stopped during the pandemic--they've just moved online... More
How to have a public health internship during a pandemic
Brooke McNaughton shares what she learned as a Lown public health intern during an unprecedented health crisis. More
Clunky EHRs hinder Covid-19 response
Like so many other aspects of our health care system, the pandemic has laid bare the flaws in our electronic health record system. More
VIDEO: Are hospitals collaborating during Covid-19?
During this unprecedented health crisis, what will it take for hospitals to put aside their rivalries and work together? Shannon Brownlee and Vikas Saini discuss in the latest edition of "Lown Hospitals Q&A." More
Key questions about remdesivir still unanswered
Since the release of the initial NIH study results, clinicians and researchers have posed many questions about remdesivir, which have so far gone unanswered. Here are a few of them... More